Cancer pain assessment and management: A survey

Journal of Back and Musculoskeletal Rehabilitation

Volumn 12, Issue 2, 1999, Pages 89-99

  Guptill, William E ^a   Carr, Daniel B ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Analgesia; Anesthesia; Cancer; Opioids; Pain

Indexed keywords

ADJUVANT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANXIOLYTIC AGENT; BUTORPHANOL; CODEINE; CORTICOSTEROID; DEXAMPHETAMINE; FENTANYL; FENTANYL CITRATE; HALOPERIDOL; HYDROCODONE; HYDROMORPHONE; LEVORPHANOL; LOCAL ANESTHETIC AGENT; METHADONE; MORPHINE; MUSCLE RELAXANT AGENT; NALBUPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OPIATE AGONIST; OXYCODONE; PARACETAMOL; PETHIDINE; SUFENTANIL;

ADVERSE DRUG REACTION; ANALGESIA; BUCCAL DRUG ADMINISTRATION; CANCER PAIN; CANCER PALLIATIVE THERAPY; CATHETER; CONFUSION; CONSTIPATION; DROWSINESS; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG COST; DRUG DELIVERY SYSTEM; DRUG DEPENDENCE; DRUG TOLERANCE; DRUG TOXICITY; DYSPHORIA; EPIDURAL DRUG ADMINISTRATION; GASTROINTESTINAL DISEASE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRASPINAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NAUSEA; NEBULIZER; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOTHERAPY; RECTAL DRUG ADMINISTRATION; REVIEW; SPINE DISEASE; SUBCUTANEOUS DRUG ADMINISTRATION; SUBLINGUAL DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION; URINE RETENTION; VOMITING; WORLD HEALTH ORGANIZATION;

EID: 0032873169     PISSN: 10538127     EISSN: None     Source Type: Journal    
DOI: 10.3233/BMR-1999-12202     Document Type: Review

References (77)

1. Jacox AK, Carr DB, Payne R, Chapman CR, Ferrell B, Fields HF, et al., Management of cancer pain. Clinical Practice Guideline No 9. AHCPR publication no. 94-0592. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, 1994.
2. Ferrante FM, Bedder M, Caplan RA, Chang HM, Connis RT, Harrison P, et al., Practice guidelines for cancer pain management, Anesthesiology 84 (1996), 1243-1257.
3. American Cancer Society, Cancer Facts and Figures-1992, Atlanta, GA: American Cancer Society Inc., 1992, pp. 2-7.
4. Bonica JI, Treatment of cancer pain: current status and future needs, in: Advances in Pain Research and Therapy, Vol. 9, Fields HL, Dubner R and Cervero, F, eds., Proceedings of the Fourth World Congress on Pain, New York: Raven Press, 1985, pp. 589-616.
5. Twycross RG, Clinical Experience with diamorphine in advanced malignant disease, Int J Clin Pharmacol Therap Toxicol 7 (1974), 184-198.
6. Daut RL and Cleeland CS, The prevalence and severity of pain in cancer, Cancer 50 (1982), 1913-1918.
7. Swerdlow M, The WHO concept of cancer pain relief, Schmerz Pain Douleur 10 (1989), 130-133.
8. World Health Organization, Cancer Pain Relief, World Health Organization Geneva, 1986.
9. Takeda F, Results of field testing in Japan of the WHO drafted interim guidelines on relief of cancer pain, Pain Clin 1 (1986), 83-89.
10. Cleeland CS, Barriers to the management of cancer pain, Oncology 25 Suppl (1987), 19-26.
11. Von Roenn JH, Cleeland CS, Gonin R, Haffield AK and Pandya KI, Physicians' attitudes and practice in cancer pain management: A survey from the Eastern Cooperative Oncology Group, Ann Intern Med 119 (1993), 121-126.
12. Grossman SA Sheidler VR, Swedeen K, Mucenski J and Piantadosi S, Correlation of patient and caregiver ratings of cancer pain, J Pain Symptom Management 6 (1991), 53-57.
13. Foley KM, The treatment of cancer pain, N Engl J Med 313 (1985), 84-95.
14. Max MB, Donovan M, Portenoy RK, Cleeland CS, Ready LB and Carr DB, American Pain Society quality assurance standards for relief of acute pain and cancer pain, in: Proceedings of the sixth world congress on pain, Bond MR, Charlton JE and Woolf CJ, eds., New York: Elsevier, 1991, pp. 185-189.
15. Kaiko RF, Foley KM, Grabinski PY, Heidrich G, Rogers AG, Inturrisi CE, et al., Central nervous system excitatory effects of meperidine in cancer patients, Ann Neurol 13 (1983), 180-185.
16. Carr DB, Jacox AK, Chapman CR, Ferrell B, Fields HL, Heidrich G III, et al., Acute pain management: operative or medical procedures and trauma. Clinical Practice Guideline No. 1. AHCPR pub. No 92-0032. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, 1992.
17. Galer BS, Coyle N, Pasternak GW and Portenoy RK, Individual variability in the response to different opioids: report of five cases, Pain 49 (1992), 87-91.
18. Ferrante FM, Ostheimer GW and Covino BG, Patient Controlled Analgesia, Boston: Blackwell Scientific Publications, 1990.
19. Lindblom U, Analysis of abnormal touch, pain and temperature sensation in patients, in: Touch, temperature, and pain in health and disease: mechanisms and assessments, Boivie J, Hansson P and Lindblom U, eds., Seattle: IASP Press, 1993, pp. 63-84.
20. Rathmell JP and Jamison RN, Opioid therapy for chronic non-cancer pain, Curr Opinion in Anesthesia 9 (1996), 436-442.
21. Schug SA and Large RG, Opioids for chronic noncancer pain, Pain: Clinical Updates 3 (1995), 1-4.
22. Krames ES, Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines, J Pain Symptom Management 11 (1996), 333-352.
23. Krames ES, Intrathecal infusional therapies for intractable pain: patient management guidelines, J Pain Symptom Management 8 (1993), 451-453.
24. De Conno F, Caraceni A, Marlini C, et al., Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine, Pain 47 (1991), 337-339.
25. Cherry DA, Gourlay GK, McLachlan M and Cousins MJ, Diagnostic epidural opioid blockade and chronic pain: preliminary report, Pain 21 (1985), 143-152.
26. Yablonski-Peretz T, Klin B, Beilin Y, Warner F, Baron S, Olshwang D, et al., Continuous epidural narcotic analgesia for intractable pain due to malignancy, J Surg Oncol 29 (1985), 8-10.
27. Paice JA, Penn RD and Shoft S, Intraspinal morphine for chronic pain: a retrospective, multicenter study, J Pain Symptom Management 11 (1996), 71-80.
28. Winkelmuller M and Winkelmuller W, Long-term effects of continuous intrathecal opioid treatment in chronic pain of non-malignant etiology, J Neurosurg 85 (1996), 458-467.
29. Hassenbusch SJ, Stanton-Hicks M, Covington EC, Walsh JG and Guthrey DS, Long-term intraspinal infusions of opioids in the treatment of neuropathic pain, J Pain Symptom Management 10 (1995), 527-543.
30. Hanks GW, De Conno F, Ripamonti C, Ventafridda V, Hanna M, McQuay HJ, et al., Morphine in cancer pain: modes of administration, Br Med J 312 (1996), 823-826.
31. Samuelson H and Hedner T, Pain characterization in cancer patients and the analgesic response to epidural morphine, Pain 46 (1991), 3-8.
32. McMahon SB, Dmitrieva N and Koltzenberg M, Visceral pain, Br J Anesth 75 (1995), 132-144.
33. Arner S and Arner B, Differential effects of epidural morphine in the treatment of cancer-related pain, Pain 29 (1985), 32-36.
34. Cousins MJ and Plummer JL, Spinal opioids in acute and chronic pain, in: Advances in pain research and therapy, Max MB, Portenoy RK and Laska EM, eds., New York: Raven Press, 1991, pp. 479.
35. Bruera E, Brennies C, Michaud M, Bacovsky R, Chadwich S, Emeno A, et al., Use of the subcutaneous route for the administration of narcotics in patients with cancer pain, Cancer 62 (1988), 407-411.
36. Kalso E, Heiskanen T, Rautio M, Rosenberg PH and Vainio A, Epidural and subcutaneous morphine in the management of cancer pain: a double-blind crossover study, Pain 67 (1996), 443-449.
37. Paix A, Coleman A, Lees J, Grigson J, Brooksbank M, Thorne D, et al., Subcutaneous fentanyl and sufentanyl infusion for morphine intolerance in cancer pain management, Pain 63 (1995), 266-269.
38. Erdine S and Aldemir T, Long-term results of peridural morphine in 225 patients, Pain 45 (1991), 155-159.
39. Yaksh TL, Intrathecal and epidural opioids: a review, in: Pain 1996-an updated review, Campbell IN, ed., Seattle: IASP Press, 1996, pp. 381-393.
40. Ballantyne JC, Carr DB, deFerranti S, Suarez T, Chalmers TC, Lau J, et al., Comparative effects of postoperative analgesic therapies upon respiratory function: meta-analyses of randomized control trials, Anesth Analg 86 (1998), 598-612.
41. Madrid IL, Fatela LV, Lobato RD and Gozalo A, Intrathecal therapy: rationale, technique, clinical results, Acta Anesthes Scand 85 Suppl (1987), 60-67.
42. Lobato RD, Madrid JL, Fatela LV, Sarabia R, Rivas JJ and Gozalo A, Intraventricular morphine for intractable cancer pain: rationale, methods, clinical results, Acta Anesthes Scand 85 Suppl 1987, 68-74.
43. Cramond T and Stuart G, Intraventricular morphine for intractable pain of advanced cancer, J Pain Symptom Management 8 (1993), 465-473.
44. Schnieder MC and Hampl KF, Complications of epidural and spinal anesthesia in adults, Curr Opin Anesthesia 8 (1995), 414-419.
45. Badner NH, Reimer EJ, Komar WE and Moote CA, Low-dose bupivicaine does not improve post-operative epidural fentanyl analgesia in orthopedic patients, Anesth Analg 72 (1991), 337-341.
46. Kamel J and Kasuya Y, The effects of diabetes on opioid induced antinociception, in: The pharmacology of opioid peptides, Tseng LF, ed., Langhorn PA: Harwood Academic Press, 1995, pp. 271.
47. Cherry DA, Gourlay GK, Cousins MJ and Gannon BJ, A technique for the insertion of an implantable portal system for the long-term epidural administration of opioids in the treatment of cancer pain, Anesth Intensive Care 13 (1985), 145-152.
48. Cherry DA, Gourlay GK and Cousins MJ, Extradural mass associated with lack of efficacy of epidural morphine and undetectable CSF morphine concentrations, Pain 25 (1986), 69-73.
49. Redd WH, Behavioral intervention for cancer treatment side effects, Acta Oncologica 33 (1994), 113-117.
50. Melzack R, Pain: past, present and future, Can J Exp Psychol 47 (1993), 615-629.
51. McGrath P and McAlpine L, Psychologic perspectives on pediatric pain, J Pediatrics 122 (1993), 52-58.
52. Syrjala KL, Cummings C and Donaldson GW, Hypnosis or cognitive behavioral training for the reduction of pain and nausea during cancer treatment. A controlled clinical trial, Pain 48 (1992), 137-146.
53. Cancer Pain Guidelines Panel: Non-pharmacologic management: physical and psychosocial modalities. In: Reference, pages 75-87.
54. Golden WL, Gersh WD and Robbins DM, Pain Control, in: Psychological treatment of cancer patients: a cognitive behavioral approach, New York, MacMillan, 1992, pp. 46-47.
55. Kirsch I and Lynn SJ, The altered state of hypnosis: changes in the theoretical landscape, Am Psychologist 50 (1995), 846-851.
56. Spira JL and Spiegel D, Hypnosis and related techniques in pain management, Hospice J 8 (1992), 89-119.
57. Montgomery G and Kirsch I, Mechanisms of placebo pain reduction: an empirical investigation, Psychol Sci 7 (1996), 174-176.
58. Meier W, Klucken M, Soyka D and Bromm, B, Hypo- and hyperalgesia: divergent effects on pain ratings and pain-related cerebral potentials, Pain 53 (1993), 175-181.
59. Kiernan BD, Dane JR, Phillips LH and Price DD, Hypnotic anagelsia reduces RIII nociceptive reflex: further evidence concerning the multi-factorial nature of hypnotic analgesia, Pain 60 (1995), 39-47.
60. Friedman R, Sobel D, Myers P, Caudill M and Benson H, Behavioral medicine clinical health psychology and cost offset, Health Psychol 14 (1995), 509-518.
61. Arcangeli G, Mieheli A, Arcangeli G, Ginnarelli D, Pasta O and Tollis A, The responsiveness of bone metastases to radio therapy: the effect of site, histology and radiation dose on pain relief, Radio Therapy Oncol 14 (1989), 95-101.
62. Maher EJ, Coia L, Duncan G and Lawton PA, Treatment strategies in advanced and metastatic cancer: differences in attitudes between the U.S.A., Canada, and Europe, Internat J Radiat Oncol Biophys 23 (1992), 239-244.
63. Nielsen OS, Munro AJ and Tannock IF, Bone metastases: pathophysiology and management policy, J Clin Oncol 9 (1991), 509-524.
64. Maxon HR III and Smith HS, Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer, Endocrinol and Metab Clinics N Amer 19 (1990), 685-718.
65. Maxon HR III, Schroder LE, Thomas SR, Hertzberg VS, Deutsch EA, Scher HI, et al., RE-186 (sn) HEDP for treatment of osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer, Radiology 176 (1990), 155-159.
66. Patt RB, Cancer pain, Philadelphia: J.B Lippincott Co., 1993.
67. Duthie AM, Ingham V, Dell AE and Dennet JE, Pituitary cryoablation: the results of treatment using a transphenoidal cryoprobe, Anesthesia 38 (1983), 448-451.
68. Wilkinson HA, Radiofrequency percutaneous upper-thoracic sympathectomy: technique and review of indications, N Engl J Med 311 (1984), 34-36.
69. Shealy CN, Mortimer JT and Roswick JB, Electrical inhibition of pain by stimulation of the dorsal column: preliminary clinical report, Anesth Analg 46 (1967), 489-491.
70. Robb L and Robb M, Practical considerations in spinal cord stimulation, Paper presented at the sixth world Congress on Pain, Adelaide, Australia 1990.
71. Melzack R and Wall PD, Pain mechanisms: a new theory, Science 150 (1965), 971-979.
72. Gybels JM and Sweet WH, eds., Spinal cord stimulation in neurosurgical treatment of persistent pain, 1989, pp. 293-302.
73. Meyerson B, Electro-stimulation procedures: effects, presumed rationale and possible mechanisms of human pain, Pain and Headache, 1983, 293-302.
74. Lindroth B, Brodin E and Grazelius B, Epidural stimulation. Poster. International Congress on Epidural Stimulation. Gruningen, the Netherlands, June 1989.
75. Freeman TB, Campbell JN and Long MD, Naloxone does not affect pain relief induced by electrical stimulation in man, Pain 17 (1983), 189-195.
76. Culic M and Jeftinija S, Effects of epidural spinal cord stimulation on the activity of lateral vestibular nucleus neurons in the cat, J Appl Neurophysiol 49 (1986), 218-228.
77. Carr DB, The WHO concept of cancer pain treatment: a guideline prototype and its context, in: Advances in Pain Therapy I, Chrubasik J, Cousins M and Martin E, eds., Berlin: Springer Verlag, 1992, pp. 8-17.